Evidence map›Paper›PMID 42846167›Full record

ArticleFrontiers in public health2026

Development and validation of an interpretable machine learning model for predicting ADHD comorbidity in children with allergic rhinitis: a SHAP-based analysis.

Hexiu Yuan, Nengjing Wu

Abstract readValidation Study
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hexiu YuanGanzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital), Ganzhou, China.
Nengjing WuFirst Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The co-occurrence of allergic rhinitis (AR) and attention-deficit/hyperactivity disorder (ADHD) presents significant clinical challenges in pediatrics, yet predictive tools capturing non-linear neuro-immune interactions are lacking. Methods: We developed an interpretable Extreme Gradient Boosting (XGBoost) model utilizing a hybrid feature selection pipeline on a cohort of 518 pediatric AR patients (255 with comorbid ADHD). Model performance was evaluated via an independent test set. Global and local interpretability was decoded using SHapley Additive exPlanations (SHAP). Results: A parsimonious subset of six predictors was identified. The XGBoost model achieved superior discriminative capacity (AUC = 0.878) compared to conventional linear baselines. SHAP topographical analysis revealed profound non-linear thresholds and uncovered a critical synergistic interaction: elevated ADHD risk was strongly correlated with patients presenting simultaneously severe allergic inflammation (Total IgE > 250 IU/mL) and nutritional deficiency (Vitamin D < 20 ng/mL). Furthermore, Decision Curve Analysis (DCA) demonstrated substantial net clinical benefit for triage application. Conclusion: We established a highly robust, interpretable machine learning algorithm capable of accurately stratifying ADHD risk among AR children. The identified neuro-immune synergistic phenotypes provide critical mechanistic insights and offer a practical decision-support tool for timely pediatric multidisciplinary interventions.

Indexed as

Attention Deficit Disorder with HyperactivityMachine LearningRhinitis, AllergicAdolescentBoosting Machine Learning AlgorithmsChildComorbidityFemaleHumansMalePredictive Learning Modelsallergic rhinitisattention-deficit/hyperactivity disordermachine learningneuro-immune crosstalkSHAP

Identifiers

PMID42846167
PMCPMC13642325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.